Steven Sherman
史蒂文·谢尔曼
MD
Professor and Chair, Department of Endocrine Neoplasia and Hormonal Disorders内分泌肿瘤与激素紊乱科教授兼主任
👥Biography 个人简介
National and international leader in thyroid cancer systemic therapy and clinical research. Has driven pivotal clinical trials of tyrosine kinase inhibitors in differentiated and medullary thyroid cancer, shaping global treatment guidelines and regulatory approvals.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
TKI Therapy in Differentiated Thyroid Cancer
Conducted foundational clinical trials of multiple TKIs including motesanib and cabozantinib in thyroid cancer, generating critical data informing FDA approvals and international guidelines.
Representative Works 代表性著作
Motesanib diphosphate in progressive differentiated thyroid cancer
New England Journal of Medicine (2008)
Demonstrated anti-tumor activity of motesanib in differentiated thyroid cancer, establishing TKI activity in this setting.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 史蒂文·谢尔曼 的研究动态
Follow Steven Sherman's research updates
留下邮箱，当我们发布与 Steven Sherman（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment